As of Feb. 5, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as ...

StockNews.com upgraded shares of Orthofix Medical (NASDAQ:OFIX – Free Report) from a hold rating to a buy rating in a report published on Friday. Other equities analysts have also recently issued ...

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday, February 25, ...

Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook.

Fintel reports that on January 22, 2025, Canaccord Genuity initiated coverage of Orthofix Medical (NasdaqGS:OFIX) with a Buy recommendation. Analyst Price Forecast Suggests 35.56% Upside As of ...

Comparatively, Orthofix Medical has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. 99.1% of AtriCure shares are owned by institutional investors. Comparatively ...

DelveInsight Analysis: The Orthopedic Trauma Devices market size is expected to grow at a CAGR of 6.43% during the forecast period (201-26) to reach USD 10.08 billion by 2030. Which MedTech key ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...